LENZ Therapeutics, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.04M15.00M
Gross Profit -0.04M15.00M
Operating items
Research & Development 9.12M59.50M29.80M
Selling, General & Administrative 4.38M12.93M28.81M
Operating Expenses 13.50M72.43M58.61M
Operating Income -13.50M-72.43M-58.61M
EBIT -13.50M-72.43M-58.61M
Non-operating items
Interest & Investment Income 2.19M8.55M
Other Non Operating Income 0.09M0.29M
Non Operating Income -54.87M2.28M8.84M
Net income details
EBT -13.54M-70.15M-49.77M
Tax Provisions -0.18M0.00M
Profit After Tax -68.37M-69.97M-49.77M
Income from Continuing Operations -13.54M-69.97M-49.77M
Consolidated Net Income -13.54M-69.97M-49.77M
Income towards Parent Company -13.54M-69.97M-49.77M
Net Income towards Common Stockholders -13.54M-69.97M-49.77M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 7.78M8.30M8.31M8.29M27.50M
Shares Outstanding (Diluted Average) 54.87M
EBITDA -13.50M-69.96M-49.58M
Shares Outstanding 58.22M
Tax Rate 0.00M